Farallon Capital Management’s Travere Therapeutics TVTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$178K	Buy	+12,000	New	+$178K	﹤0.01%	118
2024 Q1	–	Sell	-1,094,000	Closed	-$9.84M	–	185
2023 Q4	$9.84M	Buy	1,094,000 +822,483	+303%	+$7.39M	0.05%	79
2023 Q3	$2.43M	Buy	+271,517	New	+$2.43M	0.01%	104